COQ7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.005600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.620600E-01
Normal-vs-Stage2
7.748200E-01
Normal-vs-Stage3
1.824400E-02
Normal-vs-Stage4
7.466200E-01
Stage1-vs-Stage2
1.379550E-02
Stage1-vs-Stage3
2.359700E-02
Stage1-vs-Stage4
3.721400E-01
Stage2-vs-Stage3
2.681700E-02
Stage2-vs-Stage4
5.395200E-01
Stage3-vs-Stage4
7.038700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.837000E-01
Normal-vs-AfricanAmerican
5.522600E-01
Normal-vs-Asian
5.686200E-01
Caucasian-vs-AfricanAmerican
2.213000E-01
Caucasian-vs-Asian
3.768600E-01
AfricanAmerican-vs-Asian
1.574640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.395800E-01
Normal-vs-Female
9.821400E-01
Male-vs-Female
4.889400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.307600E-01
Normal-vs-Age(41-60Yrs)
9.484600E-01
Normal-vs-Age(61-80Yrs)
8.269600E-01
Normal-vs-Age(81-100Yrs)
8.428600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.660600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.461800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.927400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.197400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.905800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.644400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.718000E-01
Normal-vs-Daily Drinker
9.624400E-01
Normal-vs-Weekly Drinker
6.618800E-01
Normal-vs-Occasional Drinker
9.445400E-01
Normal-vs-Social Drinker
7.819600E-01
Non Drinker-vs-Daily Drinker
1.371380E-01
Non Drinker-vs-Weekly Drinker
4.768400E-01
Non Drinker-vs-Occasional Drinker
1.646030E-01
Non Drinker-vs-Social Drinker
8.620400E-02
Daily Drinker-vs-Weekly Drinker
5.550600E-01
Daily Drinker-vs-Occasional Drinker
9.675200E-01
Daily Drinker-vs-Social Drinker
5.377000E-01
Weekly Drinker-vs-Occasional Drinker
5.886800E-01
Weekly Drinker-vs-Social Drinker
2.772200E-01
Occasional Drinker-vs-Social Drinker
5.312800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.827500E-02
Normal-vs-Grade 2
6.161300E-03
Normal-vs-Grade 3
1.567970E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.132400E-01
Grade 1-vs-Grade 3
3.803600E-01
Grade 1-vs-Grade 4
8.827500E-02
Grade 2-vs-Grade 3
8.369200E-01
Grade 2-vs-Grade 4
6.161300E-03
Grade 3-vs-Grade 4
1.567970E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.186200E-01
Normal-vs-NonDiabetic
9.239200E-01
Diabetic-vs-NonDiabetic
5.695900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.255400E-01
Normal-vs-NoPancreatitis
7.445400E-01
Pancreatitis-vs-NoPancreatitis
1.351590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.016000E-01
Normal-vs-N1
7.429800E-01
N0-vs-N1
6.954400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.035000E-01
Normal-vs-TP53-NonMutant
6.516000E-01
TP53-Mutant-vs-TP53-NonMutant
4.407000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
